Domiphen bromide, 97%
Domiphen bromide, 97%
Domiphen bromide, 97%
Thermo Scientific Chemicals

Domiphen bromide, 97%

CAS: 538-71-6 | C22H40BrNO | 414.472 g/mol
Have Questions?
變更視圖buttonViewtableView
Quantity:
25 g
100 g
產品號碼 L12930.22
亦稱為 L12930-22
價格 (TWD)
-
Quantity:
100 g
Request bulk or custom format
化學識別
CAS538-71-6
IUPAC Namedodecyldimethyl(2-phenoxyethyl)azanium bromide
Molecular FormulaC22H40BrNO
InChI KeyOJIYIVCMRYCWSE-UHFFFAOYSA-M
SMILES[Br-].CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1
檢視更多
規格Specification Sheet規格表
Appearance (Color)White to pale yellow
FormCrystals or powder or crystalline powder or flakes
Assay (Titration ex Bromide)≥96.0 to ≤104.0%
Loss on Drying≤5.0%
Domiphen bromide is employed as a phase transfer catalyst in synthetic chemistry. It is used as a quaternary ammonium cation with cationic surfactant properties. Further, it is used as an antiseptic and an active pharmaceutical ingredient.

This Thermo Scientific Chemicals brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific Chemicals.

Applications
Domiphen bromide is employed as a phase transfer catalyst in synthetic chemistry. It is used as a quaternary ammonium cation with cationic surfactant properties. Further, it is used as an antiseptic and an active pharmaceutical ingredient.

Solubility
Soluble in ethanol, acetone, ethyl acetate, chloroform and water. Slightly soluble in benzene.

Notes
Hygroscopic. Incompatible with strong oxidizing agents.
RUO – Research Use Only

General References:

  1. Mester, P.; Gundolf, T.; Kalb, R.; Wagner, M.; Rossmanith, P. Molecular mechanisms mediating tolerance to ionic liquids in Listeria monocytogenes. Sep. Purif. Technol. 2015, 155, 32-37.
  2. Nestola, P.; Peixoto, C.; Silva, R. R. J. S.; Alves, P. M.; Mota, J. P. B.; Carrondo, M. J. T. Improved virus purification processes for vaccines and gene therapy. Biotechnol. Bioeng. 2015, 112 (5), 843-857.